FDA Inspection
Enemeez, LLC dba Summit PharmaceuticalsEnemeez, LLC dba Summit Pharmaceuticals – FDA Inspection, Feb 12, 2026
Record Details
This FDA Inspection record concerns Enemeez, LLC dba Summit Pharmaceuticals, with an inspection on February 12, 2026, issued by the Denver District Office, covering human drugs.
- Inspection Date
- February 12, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 12a25bf5-77ce-4384-a93c-ff5f6e98e524
Inspection Facts
- Inspection number
- 1302518
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.84(d)(2)Component written specification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Enemeez, LLC dba Summit Pharmaceuticals
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 29, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 10, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 6, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 12, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Enemeez, LLC dba Summit Pharmaceuticals
- FDA Inspection 1147428 - 2021-07-29
- FDA Inspection 987440 - 2016-08-10
- FDA Inspection 728243 - 2011-06-06
- FDA Inspection 656042 - 2010-03-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.